Revenue: The sum of all revenue fields included for a company's operating activities.
Summit Therapeutics PLC (SMMT) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-231.79M |
|
-- |
|
-- |
|
$234.21M |
|
$-234.21M |
|
$2.42M |
|
$-231.79M |
|
$-231.79M |
|
$-231.79M |
|
$-231.79M |
|
$-231.79M |
|
$-231.79M |
|
$-234.21M |
|
$-234.17M |
|
743.42M |
|
743.42M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$246.47M |
|
$0.81M |
|
$15.26M |
|
$261.73M |
|
$64.93M |
|
-- |
|
$4.54M |
|
$69.47M |
|
$192.26M |
|
$190.26M |
|
$192.26M |
|
744.44M |
|
| Cash Flow Statement Financials | |
$-220.99M |
|
$310.85M |
|
$43.71M |
|
$105.19M |
|
$238.88M |
|
$133.69M |
|
$620.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-221.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-120.56% |
|
-121.83% |
|
-88.56% |
|
-120.56% |
|
$0.26 |
|
$-0.30 |
|
$-0.30 |
|